Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.700
-0.130 (-4.59%)
At close: May 29, 2026, 4:00 PM EDT
2.680
-0.020 (-0.74%)
After-hours: May 29, 2026, 4:10 PM EDT

Kiora Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
127103619
Market Cap Growth
22.46%-25.16%291.62%-58.96%-67.78%-30.19%
Enterprise Value
-1.62-9.47-16.860.130.211.36
Last Close Price
2.701.973.304.7030.87543.60
PE Ratio
--3.79---
PS Ratio
--0.62---
PB Ratio
0.770.460.380.410.541.31
P/TBV Ratio
0.800.500.530.410.221.00
P/FCF Ratio
--1.16---
P/OCF Ratio
--1.16---
EV/Sales Ratio
---1.05---
EV/EBITDA Ratio
-0.74----
EV/EBIT Ratio
-0.74----
EV/FCF Ratio
-0.94----
Debt / Equity Ratio
0.010.010.000.0100.01
Debt / EBITDA Ratio
--0.01---
Debt / FCF Ratio
--0.01---
Net Debt / Equity Ratio
-0.97-1.04-1.04-0.38-0.51-0.52
Net Debt / EBITDA Ratio
1.041.31-5.900.190.480.54
Net Debt / FCF Ratio
1.281.66-3.130.250.560.71
Asset Turnover
-00.64000
Quick Ratio
6.195.624.602.762.245.21
Current Ratio
6.685.994.942.902.355.59
Return on Equity (ROE)
-30.23%-51.74%22.56%-142.88%-104.54%-113.30%
Return on Assets (ROA)
-50.77%-37.78%11.41%-78.29%-62.91%-79.24%
Return on Invested Capital (ROIC)
-273.81%-273.65%39.90%-129.77%-118.21%-121.14%
Return on Capital Employed (ROCE)
-66.64%-50.22%21.20%-91.60%-72.57%-89.42%
Earnings Yield
--26.36%---
FCF Yield
--86.37%---
Buyback Yield / Dilution
1.20%0.51%-666.73%-561.21%-203.74%-110.04%
Total Shareholder Return
1.20%0.51%-666.73%-561.21%-203.74%-110.04%
SEC Filings: 10-K · 10-Q